Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) (RICH LIFE)

June 27, 2022 updated by: Johns Hopkins University

Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities

The RICH LIFE Project is a two-armed, cluster-randomized trial, comparing the effectiveness of an enhanced standard of care arm, "Standard of Care Plus" (SCP), to a multi-level intervention, "Collaborative Care/Stepped Care" (CC/SC), in improving blood pressure control, patient activation and reducing disparities in blood pressure control among 1,890 adult patients with uncontrolled hypertension and cardiovascular disease risk factors at thirty primary care practices in Maryland and Pennsylvania. Fifteen practices randomized to the SCP arm receive standardized blood pressure measurement training, and audit and feedback of blood pressure control rates at the practice provider level. Fifteen practices in the CC/SC arm receive all the SCP interventions plus the implementation of the collaborative care model with additional stepped-care components of community health worker referrals and subspecialist curbside consults and an on-going virtual workshop for organizational leaders in quality improvement and disparities reduction. The primary clinical outcomes are the percent of patients with blood pressure <140/90 mm Hg and change from baseline in mean systolic blood pressure at 12 months. The primary patient reported outcome is change from baseline in self-reported patient activation at 12 months.

Study Overview

Detailed Description

The investigators refined research aim is to determine if a clinic-based collaborative care team, including a community health worker (CHW) to deliver community-based contextualized care, reduces disparities in blood pressure control rates, lowers cardiovascular disease (CVD) risk, and improves outcomes among patients with hypertension and other common comorbid conditions when compared to standard of care health system approaches to CVD risk management, including audit and feedback and staff and provider training.

Collaborative care includes care coordination and care management; regular and proactive monitoring and treatment to target specific patient needs using validated clinical tools and rating scales; and regular systematic caseload reviews by the care team and consultation with experts for patients who do not show clinical improvement. A typical collaborative care team includes the primary care provider, nurse care manager or coordinator, and other members of the clinic staff involved in patient care.

Intervention protocols are designed to address common comorbidities (diabetes, hyperlipidemia, depression and coronary heart disease), lifestyle factors (dietary intake, physical activity, and smoking) and medication adherence. The intensive intervention treats the "whole" patient, driven by individual patient goals and priorities, as opposed to the standard of care, which typically focuses on individual conditions. This proposed study responds directly to patient desires to feel more equipped to be involved in their care and manage multiple conditions that contribute to CVD. The investigators have worked successfully in the past with a broad range of stakeholders, including community members, patients, providers, and payors, and will continue to engage them through the research and dissemination process.

Study Type

Interventional

Enrollment (Actual)

1820

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21205
        • Johns Hopkins University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adult patients (≥21 years of age) obtaining primary care from a provider at a participating practice
  2. A diagnosis of hypertension or SBP≥140mmHg or DBP≥90mmHg twice in the past year or on antihypertensive medications plus at least one of the following CVD risk factors:

    • Diabetes mellitus (fasting blood sugar> 125mg/dl or hemoglobin A1c>6.5 or on a hypoglycemic medication);
    • Dyslipidemia (LDL >130 mg/dl, HDL<40 or total cholesterol >200 or on a lipid lowering agent);
    • Coronary heart disease
    • Current tobacco smokers
    • Depression by International Classification of Disease, 9th edition (ICD-9), codes or Patient Health Questionnaire (PHQ) score >9

Exclusion Criteria:

  1. Cardiovascular event (unstable angina, myocardial infarction) within the past 6 months
  2. Serious medical condition which either limits life expectancy or requires active management (e.g., certain cancers)
  3. Condition which interferes with outcome measurement (e.g., dialysis)
  4. Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician.
  5. Alcohol or substance use disorder if not sober/abstinent for ≥30 days
  6. Planning to leave clinic within 6 months or move out of geographic area within 18 months
  7. Individuals with cognitive impairment or other condition which makes them unable to participate in the intervention
  8. Participating in another lifestyle modification, weight reduction, or treatment trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Standard of Care Plus
The standard of care plus arm will include audit and feedback of blood pressure control rates at the provider level along with web-based training about: 1) barriers to blood pressure and cardiovascular disease (CVD) risk factors management in at-risk patient populations; 2) strategies to address healthcare disparities in clinical settings; and 3) appropriate blood pressure (BP) measurement techniques for all clinical staff. The Hopkins research team will help clinics develop audit and feedback mechanisms if they are lacking and will provide all blood pressure measurement and web-based training.
Transparent and timely access to and review of clinical performance data are among the key elements of successful improvement activities. The RICH LIFE Project provides the health systems with the logic to build practice and provider level hypertension (HTN) dashboards, support in building the dashboard, and education in utilizing the dashboard. The practice dashboard provides a display of the percentage of patients achieving BP control, defined as <140/90 mm Hg for the overall practice, while the provider dashboard provides a display of the percentage of patients achieving BP control for each provider's patient panel. Both the practice and provider Dashboards stratify hypertension performance data by race (White, non-Hispanic; Black, non-Hispanic; and All Hispanic) to help practice administration and clinicians evaluate differences between races and ethnicities in BP control rates. New reports are generated at least quarterly and will display data from the previous 3 months.
Other Names:
  • Stratified Hypertension Dashboard
All adult medicine staff at participating study practices receive standardized, evidence-based, best practices BP measurement training. Aspects of the training include proper patient preparation and positioning, how use of an automated BP measurement device, and executing a "screen and confirm" protocol when measuring patients' blood pressures.
EXPERIMENTAL: Collaborative Care/Stepped Care (CC/SC)
The CC/SC arm includes: -BP training -Audit and feedback dashboard, data stratified by race, ethnicity, payor status -A 4 hour workshop for organizational leaders in quality improvement and disparities reduction, with follow up meetings for problem-solving and support, and web-based, patient-centered communication skills training program for providers and staff -Support and guidance in establishing collaborative care model (CCM): team-based care targeting health behaviors and medication adherence. The primary care provider (PCP), care manager, CHW, and specialists in: medication management, psychosocial/behavioral, and self-management will make up the CCM team -Community health workers (CHW) working on contextualized patient interactions focused on problem-solving skills and patient self-management. CHWs will visit their patients in their homes and communities -Provider access to on-call specialists for help with patients who do not achieve BP control under the CC/SC
Transparent and timely access to and review of clinical performance data are among the key elements of successful improvement activities. The RICH LIFE Project provides the health systems with the logic to build practice and provider level hypertension (HTN) dashboards, support in building the dashboard, and education in utilizing the dashboard. The practice dashboard provides a display of the percentage of patients achieving BP control, defined as <140/90 mm Hg for the overall practice, while the provider dashboard provides a display of the percentage of patients achieving BP control for each provider's patient panel. Both the practice and provider Dashboards stratify hypertension performance data by race (White, non-Hispanic; Black, non-Hispanic; and All Hispanic) to help practice administration and clinicians evaluate differences between races and ethnicities in BP control rates. New reports are generated at least quarterly and will display data from the previous 3 months.
Other Names:
  • Stratified Hypertension Dashboard
All adult medicine staff at participating study practices receive standardized, evidence-based, best practices BP measurement training. Aspects of the training include proper patient preparation and positioning, how use of an automated BP measurement device, and executing a "screen and confirm" protocol when measuring patients' blood pressures.
This System-Level Leadership intervention aims to create a learning network through an inter-organizational approach to promote health equity and reduce CVD disparities. Elements of the system-level leadership intervention, then, include: 1) an introductory session during the kick-off event (baseline); 2) a quarterly 1 hour "content call" with a presentation on leading for equity and discussion among system-level leaders, community organization leaders, and interested practice champions in the CC/Stepped care arm conducted via conference call/webinar; and 3) monthly "coaching calls" for the system and practice level leaders, CMs, and CHWs in the CC/stepped care arm to discuss the interventions, while they are actively engaged in the intervention phase.
The collaborative care intervention creates a collaborative care team that, at a minimum, consists of PCP, nurse, or social worker care manager, and community health worker. The collaborative care team develops the medical management plan in partnership with patients; 2) uses care coordination to maximize interaction of the patients' PCPs with other care providers addressing medication management, patient self-management, and psychosocial support on a regular, consistent basis; and 3) determines patient access to CHW support and subspecialty consultations.
Other Names:
  • Collaborative Care Model
As a "stepped up" component of the Collaborative Care Team Intervention for patients needing support in overcoming a variety of social determinants
As a "stepped up" component of the Collaborative Care Team Intervention for patients with complex medical conditions and/or patients that may not typically have access to specialist care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Controlled Blood Pressure
Time Frame: 12 months
Number of participants with Controlled Blood Pressure (<140/90 mm Hg).
12 months
Patient Activation Measure (PAM-13)
Time Frame: Baseline, 12 months
The Patient Activation Measure assesses knowledge, skills, and confidence in the management of one's health. It is comprised of 13 items and each item is on a 1-5 scale. Insignia health scores on a standardized overall score of 0-100 where higher scores indicate a better outcome.
Baseline, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Systolic Blood Pressure
Time Frame: Baseline, 12 months
Mean Systolic Blood Pressure in mm Hg at baseline and 12 months.
Baseline, 12 months
Mean Diastolic Blood Pressure
Time Frame: Baseline, 12 months
Mean Diastolic Blood Pressure in mm Hg at baseline and 12 months.
Baseline, 12 months
Change in Global Framingham Risk Score
Time Frame: Baseline, 12, 24 months
Clinical Outcome
Baseline, 12, 24 months
Change in Mean Total Cholesterol (mg/dL)
Time Frame: Baseline, 12, 24 months
Clinical Outcome
Baseline, 12, 24 months
Change in Mean LDL-C (mg/dL)
Time Frame: Baseline, 12, 24 months
Clinical Outcome
Baseline, 12, 24 months
Change in Mean HDL (mg/dL)
Time Frame: Baseline, 12, 24 months
Clinical Outcome
Baseline, 12, 24 months
% With Controlled Total Cholesterol
Time Frame: Baseline
Clinical Outcome
Baseline
% With Controlled Total Cholesterol
Time Frame: 12 months
Clinical Outcome
12 months
% With Controlled Total Cholesterol
Time Frame: 24 months
Clinical Outcome
24 months
Change in Mean Glycosylated Hemoglobin (Hemoglobin A1c)
Time Frame: Baseline, 12, 24 months
Clinical Outcome
Baseline, 12, 24 months
% With Hemoglobin A1c< 7.0
Time Frame: Baseline
Clinical Outcome
Baseline
% With Hemoglobin A1c< 7.0
Time Frame: 12 months
Clinical Outcome
12 months
% With Hemoglobin A1c< 7.0
Time Frame: 24 months
Clinical Outcome
24 months
Change in Patient Assessment of Care for Chronic Conditions (PACIC-Plus)
Time Frame: Baseline, 12, 24 months
Patient Reported Outcome
Baseline, 12, 24 months
% With BP <140/90 mmHg
Time Frame: 24 months
Clinical Outcome
24 months
% With BP <130/80 mmHg
Time Frame: 12 months
Clinical Outcome
12 months
% With BP <130/80 mmHg
Time Frame: 24 months
Clinical Outcome
24 months
% With BP <120/80 mmHg
Time Frame: 12 months
Clinical Outcome
12 months
% With BP <120/80 mmHg
Time Frame: 24 months
Clinical Outcome
24 months
Change in Medication Adherence 4-Item Scale
Time Frame: Baseline, 12, 24 months
Patient Reported Outcome
Baseline, 12, 24 months
Change in Depressive Symptoms Patient Health Questionnaire (PHQ) 8 Score
Time Frame: Baseline 12, 24 months
Patient Reported Outcome
Baseline 12, 24 months
Change in Patient Ratings of Trust
Time Frame: Baseline, 12, 24 months
Patient Reported Outcome
Baseline, 12, 24 months
Change in Hypertension Knowledge and Attitudes
Time Frame: Baseline, 12, 24 months
Patient Reported Outcome
Baseline, 12, 24 months
Change in Health Related Quality of Life (PROMIS Global Scale)
Time Frame: Baseline, 12, 24 months
Patient Reported Outcome
Baseline, 12, 24 months
Change in Patient Attainment of Self-Defined Goals
Time Frame: Baseline, 12, 24 months
Patient Reported Outcome
Baseline, 12, 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa Cooper, MD, MPH, Johns Hopkins University
  • Principal Investigator: Jill Marsteller, PhD, Johns Hopkins Bloomberg School of Public Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2017

Primary Completion (ACTUAL)

February 28, 2022

Study Completion (ACTUAL)

February 28, 2022

Study Registration Dates

First Submitted

January 4, 2016

First Submitted That Met QC Criteria

February 2, 2016

First Posted (ESTIMATE)

February 4, 2016

Study Record Updates

Last Update Posted (ACTUAL)

July 1, 2022

Last Update Submitted That Met QC Criteria

June 27, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB00085630
  • UH3HL130688 (NIH)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Uncontrolled Hypertension

Clinical Trials on Provider Audit-Feedback, Stratified by Race and Ethnicity

Subscribe